Flavopiridol Synergizes with Sorafenib to Induce Cytotoxicity and Potentiate Antitumorigenic Activity in EGFR/HER-2 and Mutant RAS/RAF Breast Cancer Model Systems
Keywords: BC; breast cancer; CDKs; cyclin-dependent kinases; CI; combination index; EGFR; epidermal growth factor receptor; FFPE; formalin fixed and paraffin embedded; FISH; fluorescence in situ hybridization; FPD; flavopiridol; HER-2; ErbB2/epidermal growth factor